Paper Details

  1. Home
  2. Paper Details

Successful treatment of genotype 3 hepatitis C infection in a noncirrhotic HIV infected patient on chronic dialysis with the combination of sofosbuvir and velpatasvir: A case report.

Author: BegovacJosip, BogdanićNikolina, KrznarićJuraj, MočibobLoris, ZekanŠime

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This case report describes a patient with HCV genotype 3 and human immunodeficiency type 1 (HIV) infection on chronic dialysis who achieved a sustained virologic response after treatment with sofosbuvir/velpatasvir. The study suggests that sofosbuvir/velpatasvir may be an option for HCV genotype 3 infection in patients coinfected with HIV on long-term dialysis.
Paper Details　
Original Abstract of the Article :
RATIONALE: Data on anti-HCV therapy in patients on dialysis is still evolving. Sofosbuvir is mainly eliminated through the renal route and there is controversy about its use in these patients. PATIENT CONCERNS: We describe a 53-year-old male patient with HCV genotype 3 and human immunodeficiency ty...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320092/

データ提供：米国国立医学図書館（NLM）

Successful Treatment of Genotype 3 Hepatitis C Infection in a Noncirrhotic HIV-Infected Patient on Chronic Dialysis

This case report describes the successful treatment of genotype 3 hepatitis C infection in a noncirrhotic HIV-infected patient on chronic dialysis using the combination of sofosbuvir and velpatasvir. The patient achieved a sustained virologic response after 11 weeks of treatment, with no reported side effects. This case provides evidence that sofosbuvir/velpatasvir may be a viable option for treating HCV genotype 3 infection in patients coinfected with HIV on long-term dialysis.

Sofosbuvir/Velpatasvir: A Potential Oasis for HCV Genotype 3 Infection in Dialysis Patients

This case report offers hope for HCV genotype 3 infection in HIV-infected patients on dialysis. The success of sofosbuvir/velpatasvir treatment in this case provides a promising avenue for future treatment approaches.

Navigating the Desert of Co-Infection

This research highlights the challenges of managing co-infections, like HCV and HIV, in patients on dialysis. The successful treatment in this case demonstrates that effective therapies exist, offering a potential oasis in the desert of complex medical conditions.

Dr.Camel's Conclusion

This case report provides valuable insights into the successful treatment of HCV genotype 3 infection in a complex patient population. The successful use of sofosbuvir/velpatasvir offers hope for future treatment strategies and underscores the importance of individualized approaches to managing co-infections.

Date :
  1. Date Completed 2019-01-07
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

30572487

DOI: Digital Object Identifier

PMC6320092

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.